| | |||||||
| Ebola | |||||||
| NEWS | |||||||
Supplier of remdesivir's API under sudden focus The drug was first being developed as an investigational drug for Ebola by US-based Gilead Sciences without fanfare, but after COVID-19 broke out, ...
| |||||||
| Human, animal health linked in new exhibition Bats are a common carrier in nature, able to spread the Ebola virus without being affected by it. Other diseases such Marburg, Hendra and Nipah ...
| |||||||
| Montrose-born nurse takes over Hollywood star's social media to plea for coordinated response to ... ... Hospital & Humanitarian Health Advisor with @UKMed_NGO From the Ebola crisis to #COVID19, he'll share what he's learned on the frontlines.
| |||||||
| The first authorized drug against coronavirus in the European Union is finally Remdesivir The antiviral was developed by Gilead Science to combat the ebolavirus that causes Ebola. Objective for which it was not effective. Over time, it proved ...
| |||||||
| With High Hopes for COVID-19 Vaccine, US Scrambles to Stockpile $260M Worth of Syringes to ... "We saw it historically with Ebola, we saw it with SARS," Powell said. Bright's estimate of 850 million syringes will provide each American vaccine ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar